Immunotherapy approaches targeting regulatory T-cells

Hideya Onishi, Takashi Morisaki, Mitsuo Katano

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

The immune system prevents establishment and progression of cancer through innate and adaptive surveillance. However, some cancerous cells successfully evade the immune system. Regulatory T-cells (Tregs) facilitate such evasion. Tregs may be the factor responsible for the limited success of human tumor immunotherapy to date. To improve immunotherapy, it is thought that the number of Tregs and their functions should be inhibited in patients with advanced cancer. In this review, we focus on recent immunotherapy efforts targeting Tregs.

Original languageEnglish
Pages (from-to)997-1003
Number of pages7
JournalAnticancer research
Volume32
Issue number3
Publication statusPublished - Mar 2012

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Immunotherapy approaches targeting regulatory T-cells'. Together they form a unique fingerprint.

  • Cite this

    Onishi, H., Morisaki, T., & Katano, M. (2012). Immunotherapy approaches targeting regulatory T-cells. Anticancer research, 32(3), 997-1003.